Aadi Bioscience Stock Today
| AADI Stock | USD 2.59 0.13 4.78% |
PerformanceInsignificant
| Odds Of DistressLow
|
Aadi Bioscience is trading at 2.59 as of the 26th of February 2025. This is a 4.78 percent decrease since the beginning of the trading day. The stock's open price was 2.72. Aadi Bioscience has about a 22 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 27th of January 2025 and ending today, the 26th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 8th of August 2017 | Category Healthcare | Classification Health Care |
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California. The company has 24.7 M outstanding shares of which 706.43 K shares are presently shorted by private and institutional investors with about 2.66 trading days to cover. More on Aadi Bioscience
Moving against Aadi Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Aadi Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | David Lennon | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsAadi Bioscience can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aadi Bioscience's financial leverage. It provides some insight into what part of Aadi Bioscience's total assets is financed by creditors.
| |||||
Aadi Bioscience (AADI) is traded on NASDAQ Exchange in USA. It is located in 17383 Sunset Boulevard, Pacific Palisades, CA, United States, 90272 and employs 53 people. Aadi Bioscience is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 63.96 M. Aadi Bioscience conducts business under Biotechnology sector and is part of Health Care industry. The entity has 24.7 M outstanding shares of which 706.43 K shares are presently shorted by private and institutional investors with about 2.66 trading days to cover.
Aadi Bioscience currently holds about 118.74 M in cash with (59.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Aadi Bioscience Probability Of Bankruptcy
Ownership AllocationAadi Bioscience holds a total of 24.7 Million outstanding shares. Over half of Aadi Bioscience's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aadi Ownership Details
Aadi Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Geode Capital Management, Llc | 2024-12-31 | 217.3 K | |
| Millennium Management Llc | 2024-12-31 | 174 K | |
| Bridgeway Capital Management, Llc | 2024-12-31 | 115.4 K | |
| Northern Trust Corp | 2024-12-31 | 91.2 K | |
| State Street Corp | 2024-12-31 | 68.7 K | |
| Two Sigma Investments Llc | 2024-12-31 | 68.6 K | |
| Marquette Asset Management Inc. | 2024-12-31 | 63.6 K | |
| Two Sigma Advisers, Llc | 2024-12-31 | 61.7 K | |
| Ubs Group Ag | 2024-12-31 | 59.2 K | |
| Venbio Select Advisor Llc | 2024-12-31 | 2.8 M | |
| Qvt Financial Lp | 2024-12-31 | 2.3 M |
Aadi Bioscience Historical Income Statement
Aadi Stock Against Markets
Aadi Bioscience Corporate Management
| Neil Desai | President, Founder | Profile | |
| Raymond Steitz | Senior Officer | Profile | |
| Bryan Ball | Chief Operations | Profile | |
| Marcy Graham | SVP Communications | Profile | |
| Stephen JD | Senior Counsel | Profile | |
| Brendan MBA | Chief Officer | Profile |
Already Invested in Aadi Bioscience?
The danger of trading Aadi Bioscience is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aadi Bioscience is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aadi Bioscience. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aadi Bioscience is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.28) | Revenue Per Share | Quarterly Revenue Growth 0.21 | Return On Assets | Return On Equity |
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.